Three new cucurbitane-type triterpenoids, 5β,19-epoxy-23(R)-methoxycucurbita-6,24-dien-3β-ol (1), 5β,19-epoxy-23(S)-methoxycucurbita-6,24-dien-3β-ol (2), and 3β-hydroxy-23(R)-methoxycucurbita-6,24-dien-5β,19-olide (3), were isolated from the fruit pulp of Momordica charantia. Their structures were established on the basis of extensive NMR ( 1 H, 13 C, COSY, HMQC, HMBC, and NOESY) and EI-MS studies. Compound 1 exhibited cytotoxic activity against the SK-Hep 1 cell line.
Momordica charantia L. (Cucurbitaceae), commonly known as bitter melon, is a slender-stemmed tendril climber and is cultivated throughout the world as a vegetable crop. Tissues of this plant have extensively been used in folk medicine as a remedy for diabetes in Asia. Previous investigations have shown that the extracts and compounds of tissues of M. charantia possess cytotoxic, anti-diabetic, and anti-inflammatory activities [1] [2] [3] [4] and more than seventy cucurbitane-type triterpenes have been isolated from the fruits [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , seeds [14, 15] , root [16] , and leaves and vines [17, 18] of M. charantia. In the course of our research for bioactive secondary metabolites from Taiwanese M. charantia, we have reported the isolation and structure elucidation of twenty-five cucurbitane-type triterpenoids from the MeOH extract of the stems of this plant [19] [20] [21] [22] [23] .
In the continuing phytochemical investigation of M. charantia, we further identified three new cucurbitane-type triterpenoids, 5β,19epoxy-23(R)-methoxycucurbita-6,24-dien-3β-ol (1), 5β,19-epoxy-23(S)-methoxycucurbita-6,24-dien-3β-ol (2) , and 3β-hydroxy-23(R)-methoxycucurbita-6,24-dien-5β,19-olide (3) from the fruit pulp of M. charantia. In this paper, we report the extraction, isolation, purification, and structure elucidation of compounds 1-3 and the cytotoxic activity of compound 1.
The MeOH extract of the fruit pulp of M. charantia was suspended in water and then successively partitioned with EtOAc and n-BuOH. The combined n-BuOH soluble layer was subjected to Diaion HP-20 and silica gel column chromatography and further purification by normal phase semi-preparative HPLC to yield compounds 1-3. The structures of the three new cucurbitane-type triterpenoids were elucidated as follows. The molecular formula of compound 1 was assigned as C 31 H 50 O 3 based on the molecular ion at m/z 470.3767 in the HR-EI-MS. The IR spectrum showed absorption for a hydroxyl group (3463 cm -1 ). The 1 H and 13 C NMR spectra of 1 (Tables 1 and 2) . The 13 C NMR spectrum of 1 revealed 31 carbon signals, which were assigned by DEPT experiments as seven aliphatic methyl, one methoxy, seven aliphatic methylene, four aliphatic methine, four aliphatic quaternary, three olefinic methine, one quaternary olefinic, one secondary oxygenated, two tertiary oxygenated, and one quaternary oxygenated carbons. The spectroscopic characteristics were similar to the known compound (23E)-5β,19-epoxycucurbita-6,23-diene-3β,25-diol [19] , except for the signals of C-20-C-27. Thus, compound 1 was presumed to exhibit a 5β,19epoxycucurbita-6-en-3β-ol skeleton. The HMBC spectrum ( Figure  2 ) of 1 showed long-range correlations between H-3 (δ H 3.39) and C-1 (δ C 17.8), C-4 (δ C 37.4), and C-5 (δ C 87.8), and this suggested that one hydroxyl group was located at C-3. The HMBC correlations between H-6 (δ H 6.00)/C-4 (δ C 37.4), C-5 (δ C 87.8), C-8 (δ C 52.2), and C-10 (δ C 39.0); between H-7 (δ H 5.61)/C-5 (δ C 87.8), C-8 (δ C 52.2), C-9 (δ C 45.7) and C-14 (δ C 48.8); and between H-19 (δ H 3.48, 3.64)/C-5, C-8, C-9, C-10, and C-11 (δ C 23.8) confirmed that the oxymethylene (C-19) was linked via an oxygen atom to C-5. moiety [24] . The stereochemistry at C-23 of 1 and its epimer, compound 2, were determined to be R and S, respectively, by comparison of the 13 C NMR signals of the side-chain with those of two pairs of 23-epimer compounds, charantosides II/VI [25] and cornusalterin G/H [24] . The Δδ C values [δ C (1)-δ C (2)] for the side-chain signals were calculated as -0
, and -1.7 (C-25) from the 13 C NMR data of compounds 1 and 2 ( . The 13 C NMR spectrum of 2 revealed 31 carbon signals, which were differentiated by DEPT experiments into seven aliphatic methyl, one methoxy, seven aliphatic methylene, four aliphatic methine, four aliphatic quaternary, three olefinic methine, one quaternary olefinic, one secondary oxygenated, two tertiary oxygenated, and one quaternary oxygenated carbons. The 1 H and 13 C NMR spectra of 2 were similar to those of compound 1, except for the 13 C NMR signals from C-20 to C-27. As mentioned above, comparison of the side-chain 13 C NMR data with those of 23epimer compounds, charantosides II/VI and cornusalterin G/H [24, 25] permitted us to assign the absolute configuration of C-23 in 2 as S. The structure of 2 was consequently characterized as 5β,19epoxy-23(S)-methoxycucurbita-6,24-dien-3β-ol. 
Experimental

General experimental procedures:
Optical rotations were measured using a JASCO DIP-180 digital spectropolarimeter. The IR spectra were obtained on a Nicolet 510P FT-IR spectrometer. The NMR spectra were recorded in CDCl 3 at room temperature on a Varian Mercury plus 400 NMR spectrometer, and the solvent resonance was used as internal shift reference (TMS as standard). The 2D NMR spectra were recorded using standard pulse sequences. EI-MS and HR-EI-MS were recorded on a Finnigan TSQ-700 and a JEOL SX-102A spectrometer, respectively. TLC was performed using silica gel 60 F 254 plates (200 μm, Merck). Diaion HP-20 (Mitsubishi) and silica gel (230-400 mesh ASTM, Merck) were used for column chromatography. HPLC was performed on a Hitachi L-7000 chromatograph with a Lichrosorb Si gel 60 column (5μm, 250 × 10 mm). 
Extraction and isolation:
Oven-dried pieces of fruit pulp of Momordica charantia (35.7 kg) were extracted 3 times with methanol (100 L) at room temperature (7 days each). The MeOH extract was evaporated in vacuo to afford a black residue, which was suspended in H 2 O (6 L), and then partitioned sequentially using EtOAc and n-BuOH (4L × 3) . The n-BuOH fraction (937 g) was chromatographed over Diaion HP-20, using mixtures of water and MeOH of reducing polarity as eluents. Twenty-five fractions were collected as follows: fr. (5 × 45 cm) , eluted with CH 2 Cl 2 -MeOH (20:1 to 0:l), to obtain 5 fractions (each about 800 mL), 16A-16E. Fraction 16D was separated by semi-preparative HPLC on a Merck Lichrosorb Si 60 column (5 μm, 250 × 10 mn) with CH 2 Cl 2isopropylalcohol (20:1) as eluent, 2 mL/min, to yield 1 (13.5mg, t R = 23.8 min) and 2 (1.1 mg, t R = 24.8 min). Fraction 20 was further purified through a silica gel column (5 × 45 cm), eluted with CH 2 Cl 2 -MeOH (20:1 to 0:1) to obtain 6 fractions (each about 600 mL), 20A-20F. Fraction 20A was separated by a silica gel column (2 × 40 cm), eluted with n-hexane-acetone (10:1) to give 5 subfractions 20Aa-20Ae. 20Ab was further purified by semipreparative HPLC on a Merck Lichrosorb Si 60 column (5 μm, 250 × 10 mn) with CH 2 Cl 2 -lsopropylalcohol (20:1) as eluent, 2 mL/min, to yield 3 (1.8 mg, t R = 21.4 min).
Cytotoxicity assay:
The cytotoxicity of compound 1 was evaluated by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric method based on the described procedures [26] . SK-Hep 1 cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, L-glutamine 2 mM, 1% penicillin/streptomycin (penicillin 10000 U/mL and streptomycin 10 mg/mL) in a humidified atmosphere of 5% CO 2 at 37 °C. A volume of SK-Hep 1 cells 100 μL at a density of 1 × 10 5 cells/mL was incubated under the same conditions for 24 h in a 96-well flat-bottomed microplate. Test samples dissolved in DMSO were added to the cultures. After a 48 h incubation period, the wells were incubated with the MTT (100 μL/well concentrated at 5 mg/mL) at 37°C for 4 h. 200 μL of DMSO was added to redissolve the formazan crystals after removing the supernatant. The absorbance of the resulting formazan was measured by an enzyme-linked immunosorbent assay plate reader at 550 nm. The results were assayed in triplicate. The ratio of cell viability (%) was calculated by using the following formula: [(experimental absorbance -background absorbance)/(control absorbance -background absorbance)] × 100. The activity is shown as IC 50 value, which the concentration (μM) of the tested sample that results in 50% inhibition of cell growth. 
